Larimar Therapeutics (LRMR) Assets: 2013-2020
Historic Assets for Larimar Therapeutics (LRMR) over the last 7 years, with Sep 2020 value amounting to $114.0 million.
- Larimar Therapeutics' Assets rose 22.68% to $114.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $114.0 million, marking a year-over-year increase of 22.68%. This contributed to the annual value of $5.2 million for FY2019, which is 95.73% down from last year.
- Latest data reveals that Larimar Therapeutics reported Assets of $114.0 million as of Q3 2020, which was down 9.17% from $125.5 million recorded in Q2 2020.
- Larimar Therapeutics' Assets' 5-year high stood at $170.0 million during Q1 2016, with a 5-year trough of $5.2 million in Q4 2019.
- For the 3-year period, Larimar Therapeutics' Assets averaged around $95.6 million, with its median value being $103.9 million (2019).
- Per our database at Business Quant, Larimar Therapeutics' Assets soared by 37.07% in 2018 and then tumbled by 95.73% in 2019.
- Quarterly analysis of 5 years shows Larimar Therapeutics' Assets stood at $131.6 million in 2016, then fell by 19.84% to $105.5 million in 2017, then grew by 15.40% to $121.8 million in 2018, then slumped by 95.73% to $5.2 million in 2019, then grew by 22.68% to $114.0 million in 2020.
- Its Assets was $114.0 million in Q3 2020, compared to $125.5 million in Q2 2020 and $73.7 million in Q1 2020.